An office-based approach to emotional and behavioral risk factor reduction for cardiovascular disease

Cardiology in Review

Volumn 21, Issue 5, 2013, Pages 213-221

  Hochman, Daniel M ^a   Feinstein, Robert E ^a   Stauter, Erinn C ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Mental Health Center of Denver   (United States)

Author keywords

behavior; cardiovascular disease; risk factors

Indexed keywords

ACUTE HEART INFARCTION; ALCOHOL CONSUMPTION; ANGER; ANXIETY DISORDER; ATTRIBUTABLE RISK; BEHAVIOR; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; DEPRESSION; DISEASE ASSOCIATION; EMOTION; FRAMINGHAM RISK SCORE; HEALTH CARE PLANNING; HOSTILITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JOB STRESS; LONELINESS; META ANALYSIS (TOPIC); MOTIVATIONAL INTERVIEWING; OBESITY; PSYCHOTRAUMA; REVIEW; RISK FACTOR; RISK REDUCTION; SOCIAL STATUS; TOBACCO DEPENDENCE;

CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; EMOTIONS; HEALTH BEHAVIOR; MEDICAL HISTORY TAKING; MOTIVATION; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84883463048     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3182918f57     Document Type: Review

References (68)

1. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham study. Am J Cardiol. 1976;38:46-51.
2. Pearson T, Blair S. AHA Scientific Statement. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. Circulation. 2002;106:388-391.
3. Tennant C, McLean L. The impact of emotions on coronary heart disease risk. J Cardiovasc Risk. 2001;8:175-183.
4. Russ TC, Stamatakis E, Hamer M, et al. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.
5. Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008;118:1768-1775.
6. Khawaja IS, Westermeyer JJ, Gajwani P, et al. Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont). 2009;6:38-51.
7. Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a metaanalysis of 25 years of research. Gen Hosp Psychiatry. 2011;33:203-216.
8. Williams RB, Barefoot JC, Schneiderman N. Psychosocial risk factors for cardiovascular disease: more than one culprit at work. JAMA. 2003;290:2190-2192.
9. Rosengren A, Hawken S, Ounpuu S, et al; INTERHEART Investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953-962.
10. Albert CM, Chae CU, Rexrode KM, et al. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005;111:480-487.
11. Fleet RP, Dupuis G, Marchand A, et al. Panic disorder in coronary artery disease patients with noncardiac chest pain. J Psychosom Res. 1998;44:81-90.
12. Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med. 2004;66:645-650.
13. Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72:563-569.
14. Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol. 2009;53:936-946.
15. Yan LL, Liu K, Matthews KA, et al. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA. 2003;290:2138-2148.
16. Bunde J, Suls J. A quantitative analysis of the relationship between the Cook- Medley Hostility Scale and traditional coronary artery disease risk factors. Health Psychol. 2006;25:493-500.
17. Newman JD, Davidson KW, Shaffer JA, et al. Observed hostility and the risk of incident ischemic heart disease: a prospective population study from the 1995 Canadian Nova Scotia Health Survey. J Am Coll Cardiol. 2011;58:1222-1228.
18. Orth-Gomér K, Albus C, Bagés N, et al. Psychosocial considerations in the European guidelines for prevention of cardiovascular diseases in clinical practice: Third Joint Task Force. Int J Behav Med. 2005;12:132-141.
19. Hawkley LC, Thisted RA, Masi CM, et al. Loneliness predicts increased blood pressure: 5-year cross-lagged analyses in middle-aged and older adults. Psychol Aging. 2010;25:132-141.
20. Manrique-Garcia E, Sidorchuk A, Hallqvist J, et al. Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis. J Epidemiol Community Health. 2011;65:301-309.
21. Tsutsumi A, Kayaba K, Kario K, et al. Prospective study on occupational stress and risk of stroke. Arch Intern Med. 2009;169:56-61.
22. Kivimäki M, Virtanen M, Elovainio M, et al. Work stress in the etiology of coronary heart disease-a meta-analysis. Scand J Work Environ Health. 2006;32:431-442.
23. Chobanian Aram V., George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green, Joseph L. Izzo, Daniel W. Jones et al. "Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure." Hypertension 42, no. 6 (2003): 1206-1252.
24. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73-78.
25. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34:29-34.
26. Nouwen A, Winkley K, Twisk J, et al; European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53:2480-2486.
27. Stunkard AJ. Eating disorders and obesity. Psychiatr Clin North Am. 2011;34:765-771.
28. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-414.
29. Poirier P, Giles TD, Bray GA. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
30. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002;162:2557-2562.
31. Lahiri K, Rettig-Ewen V, B̈hm M, et al. Perceived psychosocial stress and cardiovascular risk factors in obese and non-obese patients. Clin Res Cardiol. 2007;96:365-374.
32. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275-286.
33. C enters for Disease Control and Prevention. Public health focus: physical activity and the prevention of coronary heart disease. Morb Mortal Wkly Rep. 1993;42:669-672.
34. Nocon M, Hiemann T, Müller-Riemenschneider F, et al. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2008;15:239-246.
35. Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378:1244-1253.
36. Saris WH, Blair SN, van Baak MA, et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev. 2003;4:101-114.
37. Jakicic JM, Clark K, Coleman E, et al; American College of Sports Medicine. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2001;33:2145-2156.
38. Feinstein RE, Rabinowitz PM, Carey L, et al. A model for office-based cardiovascular risk reduction and behavioral change. In: Feinstein RE, Brewer AA, eds. Primary Care Psychiatry and Behavioral Medicine: Brief Office Treatment and Management Pathways. New York: Springer; 1999:330-359.
39. Glantz S, Parmley W. Passive smoking and heart disease. Circulation. 1991;83:1-12.
40. L aw MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischemic heart disease. BMJ. 1997;315:973-980.
41. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.
42. Tolstrup J, Grønbaek M. Alcohol and atherosclerosis: recent insights. Curr Atheroscler Rep. 2007;9:116-124.
43. Fujita N, Takei Y. Alcohol consumption and metabolic syndrome. Hepatol Res. 2011;41:287-295.
44. Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and metaanalysis. BMJ. 2011;342:d671.
45. T aylor B, Irving HM, Baliunas D, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981-1990.
46. Alkerwi A, Boutsen M, Vaillant M, et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis. 2009;204:624-635.
47. Feinstein RE. Prevention-oriented primary care: a collaborative model for office-based cardiovascular risk reduction. Heart Dis. 1999;1:264-271. Available at: http://www.neurotransmitter.net/index.php. Accessed October 3, 2012.
48. Dempster M, Donnelly M. Measuring the health related quality of life of people with ischaemic heart disease. Heart. 2000;83:641-644.
49. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191-197.
50. Vazquez-Barquero JL, Vazquez BE, Herrera CS, et al. Apnish version of the new World Health Organization Disability Assessment Schedule II (WHODAS- II): initial phase of development and pilot study. Cantabria Disability Work Group. Actas Esp Psiquiatr. 2000;28:77-87.
51. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
52. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-124.
53. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 2007;32:189-198.
54. Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med. 2007;30:33-41.
55. Daeppen JB, Yersin B, Landry U, et al. Reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) imbedded within a general health risk screening questionnaire: results of a survey in 332 primary care patients. Alcohol Clin Exp Res. 2000;24:659-665.
56. Shedler J, Beck A, Bensen S: Practical mental health assessment in primary care. J Fam Pract. 2000;49:614-622.
57. Whitlock EP, Orleans CT, Pender N, et al. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002;22:267-284.
58. Prochaska JO, Norcross JC. Stages of Change. Psychother Theory Res Pract Train. 2001;38:443-448.
59. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theory Res Pract. 1982;19:276-288.
60. Wyse J, Mercer T, Ashford B, et al. Evidence for the validity and utility of the Stages of Exercise Behaviour Change scale in young adults. Health Educ Res. 1995;10:365-377.
61. Adams J, White M. Why don't stage-based activity promotion interventions work? Health Educ Res. 2005;20:237-243.
62. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York, NY: Guilford Press; 2002.
63. Martins RK, McNeil DW. Review of Motivational Interviewing in promoting health behaviors. Clin Psychol Rev. 2009;29:283-293.
64. Lai DT, Cahill K, Qin Y, et al. Motivational Interviewing for smoking cessation (Review). Cochrane Database Syst Rev 2010:CD006936.
65. Dusseldorp E, van Elderen T, Maes S, et al. A meta-analysis of psychoeduational programs for coronary heart disease patients. Health Psychol. 1999;18:506-519.
66. Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293:1626-1634. Available at: http://www.framinghamheartstudy.org/risk/index.htmlInterheart. Accessed March 6, 2012.
67. Pencina MJ, D'Agostino RB Sr, Larson MG, et al. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation. 2009;119:3078-3084.
68. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. Available at: http://epss.ahrq.gov/ePSS/search.jsp. Accessed September 20, 2012.